Skip to content

DEVANTHINIC PHARMA

Active Risk: not assessed
Private limited companyfounded 201411 yrs activeRue des Canadiens 24, 7180 Seneffe, BelgiumKBO/BCE: BE 0506.893.294
Summary

DEVANTHINIC PHARMA has a registered holding activity and consists mainly of financial fixed assets; the bankruptcy model is trained on trading and manufacturing companies and does not apply here. The 2025 annual accounts show equity of €7.7m and a net result of €888,590. Equity is growing by ~28.4% per year across the filed fiscal years. Its solvency ranks better than 54% of 2293 sector peers (fiscal year 2025). The company has been active since 2014 and the Belgian State Gazette contains no insolvency or warning signals.

Checked score

Outside the general model
Holding: general score not applicable
The company has a registered holding activity and financial fixed assets account for more than half of its assets. The general operating-company model is unsuitable for this profile, so we show no financial axes either. Filed figures remain available.
Credit check for your own amount and term

Open the credit simulator : see how the verdict changes with amount, term and advance.

Signals

1 signal. The signal on the left, the evidence on the right.
○neutral
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 27-08-2026, 27 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filings
Deviation from the deadline
2025
27 d late
2024
29 d late
2023
26 d late
2022
on the day
2021
26 d late
2020
30 d late
2019
87 d late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 32 days after the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 35% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
27-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

History

On 16 December 2014, DEVANTHINIC PHARMA was incorporated.1 Total assets went from EUR 7.5 million in 2018 to EUR 17 million in 2025 and headcount from 0.5 full-time equivalents in 2020 to 8.4 in 2025.2

  1. 1Crossroads Bank for Enterprises
  2. 2National Bank, annual accounts 2018, 2020 and 2025

Go further with this company

Is this your company? See how customers and banks see it.

Investigating this company? Keep it with today's facts in a case file.

Financials · fiscal year 2025, abbreviated schema

Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
€888,590▼ 9.6%
2024 · €983,178
Working capital
€250,353▼ 36.0%
2024 · €391,266
Trend over the years

Click a name to add, emphasise or remove a line.

Every figure with its change against the fiscal year before
favourable unfavourable
Line20212022202320242025
Operating result€847,177▲ 75.2%€970,758▲ 14.6%€943,306▼ 2.8%€818,903▼ 13.2%€703,739▼ 14.1%
Net result€825,089▲ 19.3%€1.8m▲ 113%€641,951▼ 63.4%€983,178▲ 53.2%€888,590▼ 9.6%
Equity€3.5m▲ 31.3%€5.2m▲ 50.7%€5.9m▲ 12.3%€6.8m▲ 16.8%€7.7m▲ 13.0%
Total assets€14.0m▲ 46.0%€14.4m▲ 3.0%€15.6m▲ 8.5%€16.7m▲ 6.9%€16.8m▲ 0.8%
Debt€10.5m▲ 51.6%€9.2m▼ 12.7%€9.8m▲ 6.3%€9.6m▼ 1.2%€8.7m▼ 9.7%
Working capital-€815,431▼ 274%€306,073-€18,407€391,266€250,353▼ 36.0%
Staff (FTE)1.3▲ 160%4.9▲ 277%6▲ 22.4%6.7▲ 11.7%8.4▲ 25.4%
Why a figure moved sharply
  • 2024 Net result +53% on 2023. Cause not known from the registers.
  • 2023 Net result -63% on 2022. Cause not known from the registers.
  • 2022 Net result +113%, Equity +51% on 2021. Cause not known from the registers.
Result per fiscal year
Operating resultNet result
€0€500,000€1.0m€1.5m€2.0mOperating result 2021: €847,177€847,177Net result 2021: €825,089€825,089Operating result 2022: €970,758€970,758Net result 2022: €1.8m€1.8mOperating result 2023: €943,306€943,306Net result 2023: €641,951€641,951Operating result 2024: €818,903€818,903Net result 2024: €983,178€983,178Operating result 2025: €703,739€703,739Net result 2025: €888,590€888,59020212022202320242025€0€250,000€500,000€750,000€1mOperating result 2023: €943,306€943,000Net result 2023: €641,951€642,000Operating result 2024: €818,903€819,000Net result 2024: €983,178€983,000Operating result 2025: €703,739€704,000Net result 2025: €888,590€889,000202320242025
The operating result has fallen three years in a row; 2025 is 14% below 2024 and is the lowest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €16.8m
Fixed assets €14.2m ▲ 0.3%
Current assets €2.6m ▲ 3.5%
Equity and liabilities €16.8m
Equity €7.7m ▲ 13.0%
Provisions €390,110 ▲ 86.6%
Debt €8.7m ▼ 9.7%
Debt's share of the balance-sheet total falls from 57.7% to 51.7%. Equity is higher and debt is lower.
Key figures and ratios
2025 value · change against 2024
ROE
11.5%▼
2024 · 14.4%
ROA
5.3%▼
2024 · 5.9%
Debt ≤ 1 year
€2.3m▲
2024 · €2.1m
Debt > 1 year
€6.3m▼
2024 · €7.5m
Income taxes
€158,208▼
2024 · €179,345
Staff costs
€431,503▲
2024 · €367,160
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 54 lines
Balance sheet Code20242025
Assets
Total assets20/58€16.7m€16.8m▲
Fixed assets21/28€14.2m€14.2m▲
Tangible fixed assets22/27€3,906€34,702▲
Plant, machinery and equipment23€128€517▲
Furniture and vehicles24€3,778€34,185▲
Financial fixed assets28€14.2m€14.2m▲
Current assets29/58€2.5m€2.6m▲
Amounts receivable within one year40/41€2.0m€2.2m▲
Trade receivables40€464,126€699,425▲
Other amounts receivable41€1.6m€1.5m▼
Cash at bank and in hand54/58€462,442€351,359▼
Deferred charges and accrued income490/1-€1,882
Equity and liabilities
Total equity and liabilities10/49€16.7m€16.8m▲
Equity10/15€6.8m€7.7m▲
Contributions10/11€150,000€150,000=
Reserves13€534,150€997,250▲
Non-distributable reserves130/1€15,000€15,000=
Reserves not available under the articles1311€15,000€15,000=
Tax-exempt reserves132€484,150€947,250▲
Distributable reserves133€35,000€35,000=
Profit (loss) carried forward14€6.2m€6.6m▲
Provisions and deferred taxes16€209,091€390,110▲
Provisions for liabilities and charges160/5€209,091€390,110▲
Other liabilities and charges164/5€209,091€390,110▲
Amounts payable17/49€9.6m€8.7m▼
Amounts payable after more than one year17€7.5m€6.3m▼
Financial debts170/4€7.5m€6.3m▼
Amounts payable within one year42/48€2.1m€2.3m▲
Current portion of amounts payable after more than one year42€585,500€594,027▲
Trade debts44€99,603€171,972▲
Suppliers440/4€99,603€171,972▲
Taxes, remuneration and social security45€110,385€72,526▼
Taxes450/3€75,082€10,903▼
Remuneration and social security454/9€35,303€61,624▲
Other amounts payable47/48€1.3m€1.5m▲
Income statement Code20242025
Remuneration, social security and pensions62€367,160€431,503▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€1,389€3,107▲
Provisions for liabilities and charges: additions (uses and reversals)635/8€209,091€181,018▼
Other operating charges640/8€0€1▲
Non-recurring operating charges66A€243-
Gross operating margin9900€1.4m€1.3m▼
Operating profit (loss)9901€818,903€703,739▼
Financial income75/76B€675,000€610,000▼
Recurring financial income75€675,000€610,000▼
Financial charges65/66B€331,380€266,940▼
Recurring financial charges65€331,380€266,940▼
Profit (loss) for the period before taxes9903€1.2m€1.0m▼
Income taxes67/77€179,345€158,208▼
Profit (loss) for the period9904€983,178€888,590▼
Transfer to tax-exempt reserves689€273,650€463,100▲
Profit (loss) for the period to be appropriated9905€709,528€425,490▼
Appropriation of the result
Profit (loss) to be appropriated9906€6.2m€6.6m▲
Profit (loss) brought forward from the previous period14P€5.5m€6.2m▲
Social balance
Average headcount (FTE)90876.78.4▲

The notes to these accounts (13 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line20212022202320242025Change
Remuneration, social security and pensions62€68,070€233,802€284,874€367,160€431,503▲ 17.5%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€14,910€2,739€4,389€1,389€3,107▲ 124%
Provisions for liabilities and charges: additions (uses and reversals)635/8---€209,091€181,018▼ 13.4%
Other operating charges640/8-€868€1€0€1▲ 2,380%
Non-recurring operating charges66A---€243--
Gross operating margin9900€930,157€1.2m€1.2m€1.4m€1.3m▼ 5.5%
Operating profit (loss)9901€847,177€970,758€943,306€818,903€703,739▼ 14.1%
Financial income75/76B€350,000€1.2m€110,000€675,000€610,000▼ 9.6%
Recurring financial income75€350,000€1.2m€110,000€675,000€610,000▼ 9.6%
Financial charges65/66B€206,327€181,708€227,909€331,380€266,940▼ 19.4%
Recurring financial charges65€206,327€181,708€227,909€331,380€266,940▼ 19.4%
Profit (loss) for the period before taxes9903€990,850€2.0m€825,397€1.2m€1.0m▼ 10.0%
Transfer from deferred taxes780-€1,650----
Income taxes67/77€165,761€204,797€183,447€179,345€158,208▼ 11.8%
Profit (loss) for the period9904€825,089€1.8m€641,951€983,178€888,590▼ 9.6%
Transfer to tax-exempt reserves689--€210,500€273,650€463,100▲ 69.2%
Profit (loss) for the period to be appropriated9905€825,089€1.8m€431,451€709,528€425,490▼ 40.0%
Line20212022202320242025Change
Assets
Total assets20/58€14.0m€14.4m€15.6m€16.7m€16.8m▲ 0.8%
Fixed assets21/28€12.6m€12.6m€13.8m€14.2m€14.2m▲ 0.3%
Tangible fixed assets22/27€5,742€10,427€16,537€3,906€34,702▲ 788%
Plant, machinery and equipment23-€739€433€128€517▲ 303%
Furniture and vehicles24€5,742€9,689€16,104€3,778€34,185▲ 805%
Financial fixed assets28€12.6m€12.6m€13.8m€14.2m€14.2m▲ 0.1%
Current assets29/58€1.4m€1.8m€1.8m€2.5m€2.6m▲ 3.5%
Amounts receivable within one year40/41€1.1m€1.4m€1.5m€2.0m€2.2m▲ 9.7%
Trade receivables40€315,335€222,314€243,340€464,126€699,425▲ 50.7%
Other amounts receivable41€786,980€1.2m€1.3m€1.6m€1.5m▼ 2.4%
Cash at bank and in hand54/58€285,568€401,330€213,315€462,442€351,359▼ 24.0%
Deferred charges and accrued income490/1€3,908€24,220€17,406-€1,882-
Equity and liabilities
Total equity and liabilities10/49€14.0m€14.4m€15.6m€16.7m€16.8m▲ 0.8%
Equity10/15€3.5m€5.2m€5.9m€6.8m€7.7m▲ 13.0%
Contributions10/11€150,000€150,000€150,000€150,000€150,000=
Reserves13€50,000€50,000€260,500€534,150€997,250▲ 86.7%
Non-distributable reserves130/1€15,000€15,000€15,000€15,000€15,000=
Reserves not available under the articles1311€15,000€15,000€15,000€15,000€15,000=
Tax-exempt reserves132--€210,500€484,150€947,250▲ 95.7%
Distributable reserves133€35,000€35,000€35,000€35,000€35,000=
Profit (loss) carried forward14€3.3m€5.0m€5.5m€6.2m€6.6m▲ 6.9%
Provisions and deferred taxes16---€209,091€390,110▲ 86.6%
Provisions for liabilities and charges160/5---€209,091€390,110▲ 86.6%
Other liabilities and charges164/5---€209,091€390,110▲ 86.6%
Amounts payable17/49€10.5m€9.2m€9.8m€9.6m€8.7m▼ 9.7%
Amounts payable after more than one year17€8.3m€7.7m€8.0m€7.5m€6.3m▼ 15.5%
Financial debts170/4€8.3m€7.7m€8.0m€7.5m€6.3m▼ 15.5%
Amounts payable within one year42/48€2.2m€1.5m€1.8m€2.1m€2.3m▲ 10.9%
Current portion of amounts payable after more than one year42€477,629€526,532€563,524€585,500€594,027▲ 1.5%
Financial debts43€4,702-----
Credit institutions430/8€4,702-----
Trade debts44€15,478€44,211€51,366€99,603€171,972▲ 72.7%
Suppliers440/4€15,478€44,211€51,366€99,603€171,972▲ 72.7%
Taxes, remuneration and social security45€102,972€81,473€43,071€110,385€72,526▼ 34.3%
Taxes450/3€93,595€55,284€18,270€75,082€10,903▼ 85.5%
Remuneration and social security454/9€9,377€26,189€24,801€35,303€61,624▲ 74.6%
Other amounts payable47/48€1.6m€847,304€1.1m€1.3m€1.5m▲ 14.2%
Line20212022202320242025Change
Profit (loss) for the period9904€825,089€1.8m€641,951€983,178€888,590▼ 9.6%
+ Depreciation and write-downs630€14,910€2,739€4,389€1,389€3,107▲ 124%
Operating cash flow (approximation)€839,999€1.8m€646,339€984,567€891,697▼ 9.4%
Investment in fixed assets (approximation)--€7,424-€1.2m-€344,489-€44,601▲ 87.1%
Change in cash-€115,763-€188,016€249,127-€111,083▼ 145%

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
27-08
NBB filing Annual accounts filed
fiscal year 2025 · abbreviated schema · 27 days late
2025
29-08
NBB filing Annual accounts filed
fiscal year 2024 · full schema · 29 days late
2024
26-08
NBB filing Annual accounts filed
fiscal year 2023 · full schema · 26 days late
2023
31-07
NBB filing Annual accounts filed
fiscal year 2022 · full schema
2022
31-12
Financial Highest result since 2018net €1.8m ▲113%
Operating result €970,758, net result €1.8m, both a record.
31-12
Financial Equity above €5mEq €5.2m ▲50.7%
5 profitable years in a row build equity to €5.2m.
26-08
NBB filing Annual accounts filed
fiscal year 2021 · full schema · 26 days late
2021
30-08
NBB filing Annual accounts filed
fiscal year 2020 · full schema · 30 days late
2020
31-12
Financial Equity above €2mEq €2.6m ▲35.5%
3 profitable years in a row build equity to €2.6m.
26-10
NBB filing Annual accounts filed
fiscal year 2019 · micro schema · 87 days late
2019
31-12
Financial Weakest financial yearnet €407,263 ▼67.8%
Net result drops to €407,263, the lowest in the series; recovery starts the following year.
09-09
NBB filing Annual accounts filed
fiscal year 2018 · micro schema · 40 days late
2018
02-08
NBB filing Annual accounts filed
fiscal year 2017 · micro schema · 2 days late
2017
08-08
NBB filing Annual accounts filed
fiscal year 2016 · full schema · 8 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 8 acts read
About the unread acts

We know of 8 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Directors
8 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Seneffe · 1 establishment unit since 2014
seat establishment The establishment unit on the map
Ground area
2,402 m²
Building footprint
339 m²
Parcel 52063C0201/00F007, Wallonia. Linked by address, not a title deed.
13 companies at this address See who is registered here
1 establishment unit
Rue des Canadiens 24, 7180 Seneffe
Holdings
since 20142.237.633.315
1 parcel
Wallonia 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
52063C0201/00F007 Wallonia 2,402 m² 1 · 339 m² -
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Structure & network

Owners and holdings

12 holdings

Owners 0

The accounts to 31-12-2025 list no shareholders, and no other source names one.

Holdings 12

Show 2 more holdings

According to the 2025 annual accounts of DEVANTHINIC PHARMA and those of the other companies, the acts in the Belgian Gazette and the LEI register. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not fill in these statements, or need not, is missing.

Connections & network

No current directors or connected companies found in the register.

Recognitions · licences · registrations

Legal Entity Identifier

9845005496B8A81C7768
live in the LEI register

Similar companies · same sector, comparable size

Of 24,517 companies in sector 82990 we hold annual accounts for 9,415. 1,380 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector

Identification & contact

Identification
Legal formPrivate limited company
Founded16-12-2014
Fiscal year end31-12
Activities, NACEBEL 2025
64210Activities of holding companies
82990Other business support services
E-invoicing
Reachable via Peppol
Peppol ID 0208:0506893294
Also 9925:BE0506893294
Registered 29-12-2025

Register as of 26 September 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.